career opportunities  sientra investors    news    contact    careers    resources home products our services meet sientra we help build relationships and careers sientra is headquartered in santa barbara california known for its idyllic weather and fresh ocean air and just a mile from spectacular coastline views please visit our careers website if you are interested in learning about the exciting employment opportunities here compliance  sientra investors    news    contact    careers    resources home products our services meet sientra compliance in  sientra adopted a comprehensive compliance program in accordance with the compliance program guidance for pharmaceutical manufacturers provided by the office of the inspector general of the united states department of health and human services sientra expects employees to comply with its comprehensive compliance program and has made a goodfaith effort to enforce its comprehensive compliance program prevent violations and address any inappropriate conduct that may occur on january   sientra declared that it is in compliance with a california health and safety code sections  and  and b sientras comprehensive compliance policy and code of conduct regarding health care regulatory matters copies of this declaration and sientras comprehensive compliance policy and code of conduct regarding health care regulatory matters may be obtained by calling  additionally as required under section  of the california health and safety code sientra has established an annual company spending limit on promotional items or activities provided to medical or health professionals licensed in california sientras annual spending limit is  for activities occurring between january    december   meet our leadership  sientra investors    news    contact    careers    resources home products our services meet sientra building partnerships based on experience decades of it at sientra we believe that shared expertise and values are essential components of success our leadership is driven by decades of experience and skill that help bring your goals and aesthetic visions to life click an image jeffrey nugent chairman and chief executive officer jeffrey nugent joined sientra in  as a board member prior to becoming the chairman and ceo in  mr nugent’s experience includes serving as the ceo and worldwide president of neutrogena where he led the acquisition by johnson  johnson neutrogena is regarded as one of the most successful acquisitions in jj history following neutrogena mr nugent became the president and ceo of revlon where he led a turnaround in profitability and a global initiative of new product innovation he was founder president and ceo of precision dermatology a multichannel dermatology and skin care company he established in  the company grew both organically and by ma and was acquired by valeant pharmaceuticals in  he began his career at johnson  johnson where he held a number of senior responsibilities in general management research finance marketing and manufacturing across pharmaceutical medical device and consumer franchises he was appointed vice president of worldwide quality most recently mr nugent had been interim president chief executive officer and a director of biolase inc mr nugent has also served as chairman director president and chief executive officer of a number of aesthetic medicine medical device and consumer focused companies including bioform inc prior to its acquisition by merz aesthetics inc he has also served on the board of the child welfare league of america mr nugent holds a bs in mathematics from st josephs college and earned an mba in finance and marketing from loyola university in chicago he served as an artillery officer in the us army while assigned to military intelligence at the pentagon deborah bettencourt vice president customer experience and corporate administration deborah bettencourt joined sientra in  ms bettencourt has nearly  years of experience in corporate operations and information technology within the medical device industry she spent much of her professional career at inamed corporation currently allergan medical ms bettencourt served as director of information technology at inamed corporation where she was as an integral part of global information technology implementations business acquisitions system and process integrations and international manufacturing expansions ms bettencourt is a member society for human resource management shrm and holds a ba in psychology from the university of california at santa barbara ms bettencourt also serves on the board of trustees for marymount of santa barbara dan carlisle vice president of product technology and manufacturing dan carlisle joined sientra in  mr carlisle has nearly  years of innovative product design and development experience as well as technical expertise in the aestheticsurgical market prior to joining sientra mr carlisle was senior director technical marketing at inamed corporation currently allergan medical where he was responsible for designing refining and improving new products for the global aesthetic market additionally he served as director of the internationally recognized inamed academy™ currently allergan academy ® a global education and training platform for surgeons he is named inventor or coinventor on numerous patents in the aesthetic plastic surgery field before inamed mr carlisle held various management positions at silimed corporation based out of brazil and at mcghan medical mr carlisle holds a ba in art from california state university at northridge rosalyn d’incelli vice president clinical operations and medical affairs rosalyn d’incelli joined sientra in  ms d’incelli has more than  years of clinical research experience coupled with an accomplished record of clinical achievements prior to joining sientra she was the director of clinical studies at mentor corporation where she oversaw many of the company’s studies and managed their clinical resources ms d’incelli was a significant contributor to mentor’s successful siliconegel pma approval and at the time led the company’s large postapproval siliconegel study additionally she served as clinical director for mentor’s phase  botulinum toxin studies and was previously involved in multiple urology studies prior to joining mentor ms d’incelli was employed at inamed corporation currently allergan medical in clinical operations where she was a member of the clinical study team seeking approval for the company’s siliconegel pma she has a demonstrated successful track record in the area of clinical operations with notable clinical studies completions in the areas of breast and facial aesthetics and marketing approvals ms d’incelli holds a ba from the university of california santa barbara and is socra board certified in clinical research joann kuhne vice president regulatory affairs and quality assurance joann kuhne joined sientra in  ms kuhne has more than twenty years of global regulatory and clinical experience prior to joining sientra ms kuhne served as senior director regulatory affairs at inamed corporation now allergan medical where she was instrumental in the company’s efforts to obtain pma approval for the company’s silicone gel breast implants before inamed ms kuhne was director of regulatory  clinical affairs at medtronic ps medical leading the company’s global regulatory and clinical efforts for its neurosurgical implants preceding her career at medtronic ps medical and inamed ms kuhne spent several years in the orthopedic implant industry as manager of regulatory affairs for smith and nephew orthopedics and intermedics orthopedics ms kuhne received her bsn from northern michigan university in marquette michigan and an msn from the university of north carolina at chapel hill she is a member of the sigma theta tau international honor society and is board certified in regulatory affairs ms kuhne is an active volunteer at the santa ynez valley therapeutic riding center and is a sponsor for threshold ministries and impact  rich low vice president of marketing rich low brings more than  years of experience in the aesthetic medicine industry to sientra prior to joining sientra mr low held senior positions at mentor corporation ww llc a division of johnson  johnson where he was responsible for a wide variety of upstream and downstream marketing initiatives in the plastic surgery and nonsurgical markets including new technology development and market creation mr low has introduced a significant number of new products to the aesthetic surgical market including topselling breast implants and breast tissue expanders additionally he led the introduction of new injectable products to europe latin america canada and asia and topical skin care treatments in the us mr low holds an mba from the anderson school of management at ucla an undergraduate degree from uc riverside with a year of undergraduate work at victoria university in wellington new zealand mr low is on the board of directors of the immune deficiency foundation which works to raise funds and awareness for people born with primary immune deficiencies jason o’hearn vice president of sales jason o’hearn brings more than  years of aesthetic medical device experience to sientra  of those years were spent in seniorexecutive management positions prior to joining sientra mr o’hearn was vice president of sales at mentor corporation ww llc a division of johnson  johnson he was responsible for leading a team of approximately  sales professionals and his efforts resulted in mentor becoming a world leader in breast implant sales mr o’hearn played a vital role in the introduction and acceptance of silicone gel implants into the us market and he has demonstrated a successful track record of moving market share in a highly competitive market mr o’hearn holds ba in business management and a minor in finance from san diego state university mr o’hearn is a volunteer for the mesa beautification committee which raises funds and awareness on how to keep our santa barbara beaches and parks clean patrick f williams chief financial officer senior vice president and treasurer patrick f williams joined sientra in  he brings with him nearly  years of financial and operational management experience with public companies most recently serving as senior vice president and chief financial officer at zeltiq aesthetics a medical technology company focused on developing and commercializing products utilizing its proprietary controlledcooling technology platform mr williams was at zeltiq for approximately four years and was responsible for executive management of the finance information technology and investor relations functions development of the worldwide budget and forecast and implementation of necessary infrastructure changes to support topline growth and operating margin expansion prior to zeltiq mr williams served as vice president of strategy and investor relations and vice president of finance and investor relations at nuvasive a medical device company focused on developing minimally surgical products for the spine mr williams also currently serves on the board of directors of miramar labs a medical device company that markets miradry® a system designed for the treatment of hyperhidrosis mr williams received an mba in finance and management from san diego state university and a bachelor of arts in economics from university of california san diego charlie huiner chief operating officer and senior vice president of corporate development and strategy charlie huiner joined sientra in  and brings with him a successful track record of more than  years in business development marketing and strategy where in the past  years he served in senior roles in the medical technology and device industries mr huiners medical device and aesthetics experience includes  years at inamed now allergan medical where as senior director of corporate development and strategy his responsibilities spanned business development strategy corporate communications and investor relations at inamed mr huiner served a core role in a number of important partnership and inlicensing transactions including the acquisition of juvéderm® and he was also part of the senior transaction team that executed the  billion sale of inamed to allergan medical immediately prior to joining sientra mr huiner was at intouch health where he served as vice president of business development and marketing at intouch health he led a number of important strategic growth initiatives including conceiving of building and leading the companys btob surgical collaboration business his extensive transactional and strategy transformation expertise is grounded by early career experience in operating and investing roles with security capital group now ge capital and prologis trust he began his career as an ma financial analyst for natwest bancorp mr huiner earned a ba in history from williams college and an mba in finance and marketing from northwestern universitys kellogg school where he concentrated in healthcare management vidur sahney vice president operations and supply chain vidur sahney joined sientra in  having had similar operations leadership roles over the past  years with thoratec now st jude medical loma vista medical now bard peripheral vascular abbott vascular and abbott diabetes care most recently mr sahney served as the senior director of operations at thoratec and was responsible for commercializing and leading the heartmate php program resulting in a successful acquisition by st jude medical prior to this he served as the director of operations for loma vista medical where he helped take a novel class iii fiber composite balloon catheter from conception to commercialization also resulting in an acquisition by bard peripheral vascular mr sahney holds a bs in mechanical engineering from san francisco state university and he learned the fundamentals of lean manufacturing from toyota’s north american contract manufacturer new united motors manufacturing inc or nummi link  jeffrey nugent chairman  chief executive officer deborah bettencourt vice president customer experience  corporate administration dan carlisle vice president of product technology  manufacturing rosalyn dincelli vice president clinical operations  medical affairs charlie huiner chief operating officer  senior vice president of corporate development  strategy joann kuhne vice president regulatory affairs  quality assurance rich low vice president of marketing jason ohearn vice president of sales vidur sahney vice president operations  supply chain patrick f williams chief financial officer senior vice president  treasurer find a boardcertified plastic surgeon near you  sientra find a boardcertified surgeon get a grasp of our products feel confident just a touch more information feel so good youll want to share breast implants are supposed to feel as good as they look thats why sientra breast implants are made with highstrength cohesive silicone gel which helps to provide implant strength and integrity while still feeling like a natural part of your body and because we insist on only the very best sientra breast implants are only available through boardcertified or boardeligible plastic surgeons so that you feel the best about your breast surgery result sientra now offers biocorneumâž the physicians choice for advanced scar treatment find your plastic surgeon today to find a qualified plastic surgeon near you enter your zip code below search please enter a valid digit zip code privacy statement terms of use safety information compliance resources   sientra inc all rights reserved contact information  sientra investors    news    contact    careers    resources home products our services meet sientra we look forward to hearing from you at sientra the level of excellence found in our products is also present in the support and unsurpassed service we give to our customers mailing address sientra inc  s fairview avenue suite  santa barbara california  email infosientracom phone for product orders or product information phone   fax   for general inquiries phone   fax     contact form if you prefer that we contact you please submit your information below required fields are noted with an asterisk first name last name email address company name phone request description we respect your privacy your personal information is confidential and will not be sold or rented read our privacy statement sientra  beauty investors    news    contact    careers    resources home products our services meet sientra the leading scar treatment has a beautiful new look we’ve redesigned the brand to reflect the quality of biocorneum® the only advanced scar treatment with fdacleared silishield™ patented crosslinking silicone plus the protection of spf  click here to visit biocorneumcom were expanding our family we’re proud to announce the addition of allox® and dermaspan™ to our portfolio of breast tissue expanders our growing product line of innovative premium expanders offers simplicity of choice with oneofakind features that meet the highly individualized needs of breast reconstruction patients learn more reshaping theway business is done at sientra we understand dedication thats why we cater exclusively to boardcertified plastic surgeons as you deliver on the high expectations of your patients each day well be doing the same for you with innovative products and unsurpassed service options you asked for introducing sientras growing portfolio of smooth round breast implants our new options feature more projections and a higher fill ratio learn more about our breast implants we want yourpatients to feel good women want their breast implants to feel as good as they look our patient website gives them the information they need to get started on their journey click here to visit our patient website relax youre covered standing by you your patientsand our products we have complete confidence in our products and you should too thats why we were the first company to offer animplant replacement program for capsular contracture learn more about the capcon care program service its why were here with leadership composed of highly experienced veterans in the field of plastic surgery sientra has an unwavering commitment to serving its customers meet sientra home home home ourproducts forpatients ourservices meetsientra sientra inc private company information  bloomberg july    pm et healthcare equipment and supplies company overview of sientra inc snapshot people company overview sientra inc a medical aesthetics company develops and sells medical aesthetics products to plastic surgeons in the united states the company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures and breast tissue expanders it also provides body contouring products facial and nasal implants scar management products under the biocorneum and silishield brand names salinefilled breast implant sizers to identify the correct style and size of implants and nonbreast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use the company was formerly known as juliet medical inc and changed it sientra inc a medical aesthetics company develops and sells medical aesthetics products to plastic surgeons in the united states the company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures and breast tissue expanders it also provides body contouring products facial and nasal implants scar management products under the biocorneum and silishield brand names salinefilled breast implant sizers to identify the correct style and size of implants and nonbreast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use the company was formerly known as juliet medical inc and changed its name to sientra inc in april  sientra inc was incorporated in  and is headquartered in santa barbara california detailed description  south fairview avenuesuite santa barbara ca united statesfounded in  employees phone  fax  wwwsientracom key executives for sientra inc mr jeffrey m nugent chairman and chief executive officer age  total annual compensation k mr patrick f williams chief financial officer senior vice president and treasurer age  total annual compensation k mr charles huiner chief operating officer and senior vice president of corporate development  strategy age  total annual compensation k compensation as of fiscal year  sientra inc key developments miramar labs inc sientra inc  ma call jun   to discuss the acquisition between miramar labs inc and sientra inc sientra inc presents at the william blair  growth stock conference jun  am jun   sientra inc presents at the william blair  growth stock conference jun  am venue the four seasons hotel  east delaware place chicago il  united states speakers jeffrey m nugent chairman and chief executive officer patrick f williams chief financial officer senior vice president and treasurer sientra inc reports unaudited earnings results for the first quarter ended march   may   sientra inc reported unaudited earnings results for the first quarter ended march   for the quarter the company reported net sales of  against  a year ago loss from operations was  against  a year ago loss before income taxes was  against  a year ago net loss was  or  basic and diluted per share attributable to common stock holders against  or  basic and diluted per share attributable to common stock holders a year ago net cash used in by operating activities was  against  a year ago purchase of property and equipment was  against  a year ago adjusted ebitda was  against  a year ago similar private companies by industry company name region decimal inc united states  genesystems inc united states  imaging llc united states st century scientific inc united states x corporation united states recent private companies transactions typedate target mergeracquisition june   miramar labs inc mergeracquisition november   specialty surgical products inc tissue expander portfolio request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact sientra inc please visit wwwsientracom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close sientra® acquires tissue expander portfolio from specialty surgical products inc  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street sientra® acquires tissue expander portfolio from specialty surgical products inc globenewswire nov    pm est highlights acquisition of specialty surgical products ssp comprehensive tissue expander portfolio includes the recently introduced allox ® patented dual port expanders leverages sientra sales force while adding select ssp independent sales agents to strengthen tissue expander distribution into the hospital channel santa barbara calif nov   globe newswire  sientra inc nasdaqsien a medical aesthetics company today announced the acquisition of a complete portfolio of premium differentiated tissue expanders from industry pioneer specialty surgical products inc ssp with this acquisition sientra adds to its product offering the allox and dermaspan™ lines of breast tissue expanders in addition to the softspan™ line of extremity expanders jeffrey nugent chairman and chief executive officer of sientra said this acquisition represents another important step in building the sientra platform and positioning the business for future growth in the  million us tissue expander and gel implant breast reconstruction market as we look to further strengthen our efforts in this area it is a natural portfolio extension for sientra and provides a premium expander line to build upon in a market where the standard of care often begins with breast tissue expansion and follows with silicone gel implants  mr nugent continued in addition this acquisition will enable us to leverage and expand our sales distribution while broadening our product portfolio with a wellestablished line of expanders in the case of the dual port allox we now have a truly innovative solution designed to address postsurgical seromas and infection with its patented and novel drainage system with early promising clinical performance and results confirmed by key opinion leaders we are confident in the value of this product portfolio and look forward to building on these results as we continue to expand the clinical evidence behind these products if you liked this article you might like  stocks triggering breakout trades these stocks are setting up to break out and trade higher from current levels roberto pedone jun    am edt  bestperforming smallcap stocks in  smallcap stocks are taking a beating this month due to market volatility but there are outliers in the group here are the  bestperforming russell  stocks this month laurie kulikowski jan    pm est  stocks under  set to soar these stocks trading for less than  a share look ready to break out and trade higher from current levels roberto pedone dec    am est  stocks under  to trade for breakouts these stocks trading for less than  a share are within range of triggering breakout trades roberto pedone oct    pm edt trending starbucks shares are plunging by more than   go out and buy worst performing tech stocks amzn amd mu wdc tesla is a cult stock jim cramer says how do i hate thee amazon let me count the ways us steel shares are being torched thanks to one stock analyst advertising partners  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers sientra inc  nasdaqsien  stock quote  news  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street sientra inc sien follow    nasdaq  health care jul    pm edt prev close  open  day lowhigh     wk lowhigh    volume k avg volume k exchange nasdaq shares outstanding m market cap m eps  pe ratio na div  yield na na trade with jim cramer  days free latest news sientra completes acquisition of miramar labs® sientra to present at the canaccord genuity growth conference sientrar to release second quarter  financial results and host conference call on wednesday august   jul    am edt sientra to acquire miramar labs® jun    am edt sientra to present at the william blair th annual growth stock conference jun    am edt sientra® reports first quarter  financial results remains on track for fda pma supplement approval by end of  may    pm edt sientra® to release first quarter  financial results and host conference call on tuesday may   apr    am edt sientra is now oversold sien legendary investor warren buffett advises to be fearful when others are greedy and be greedy when others are fearful one way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the relative strength index or rsi which measures momentum on a scale of zero to  apr    pm edt sientra secures  million credit facility from silicon valley bank mar    am edt sientra reports fourth quarter and full year  financial results mar    pm edt sientra reports inducement grant under nasdaq listing rule c mar    pm est sientra appoints vidur sahney as vice president operations and supply chain experienced medical device manufacturing executive to lead resupply initiatives and support new product pipeline development and innovation activities mar    pm est sientra® to release fourth quarter and full year  financial results and host conference call on tuesday march   feb    am est sientra appoints aesthetic industry leader philippe a schaison to board of directors former president of allergans aesthetic and dermatology business adds deep industry expertise feb    am est sientra® receives fda approval of new silicone breast implant styles and sizes dec    pm est sientra to present at investor conferences in november  nov    am est sientra® reports third quarter  financial results nov    pm est sientra® acquires tissue expander portfolio from specialty surgical products inc targets the m us breast reconstruction market with portfolio of premium breast tissue expander products nov    pm est sientra reports inducement grant under nasdaq listing rule c nov    am edt sientra is now oversold sien legendary investor warren buffett advises to be fearful when others are greedy and be greedy when others are fearful one way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the relative strength index or rsi which measures momentum on a scale of zero to  oct    pm edt sientra® reaches preliminary settlement of shareholder class action litigation oct    am edt sientra® to release third quarter  financial results and host conference call on tuesday november   oct    am edt sientra announces chief financial officer transition appoints patrick f williams as chief financial officer oct    am edt shareholder alert levi  korsinsky llp announces an investigation involving possible breaches of delaware law by the board of sientra inc levi  korsinsky announces it has commenced an investigation of sientra inc sep    pm edt sientra sien shareholder alert  andrews  springer llc is investigating sientra inc for potential breaches of fiduciary duty andrews  springer llc a boutique securities class action law firm focused on representing shareholders nationwide is investigating potential breach of fiduciary duty claims against sientra inc sep    am edt sientra® reports second quarter  financial results and progress on manufacturing solution aug    am edt sientra® provides update on manufacturing solution announces services agreement with vesta aug    am edt sientra® to release second quarter  financial results and host conference call on tuesday august   jul    am edt  stocks triggering breakout trades these stocks are setting up to break out and trade higher from current levels jun    am edt sientra is now oversold sien legendary investor warren buffett advises to be fearful when others are greedy and be greedy when others are fearful one way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the relative strength index or rsi which measures momentum on a scale of zero to  may    pm edt next load more quant rating on  pm edt  d sell get the sien report here from our partners midday gainers  losers seekingalpha sientra initiated with an overweight at stephens the fly sientra sien presents at the william blair  growth stock conference  slideshow seekingalpha sientra takes out miramar labs for up to m mrlb down  seekingalpha sientra sien acquires miramar labs mrlb  slidehow seekingalpha sientra misses by  beats on revenue seekingalpha sientra initiated with a buy at lake street the fly sientra beats by  misses on revenue seekingalpha notable earnings after tuesday’s close seekingalpha jjs mentor unit sued over leaking breast implants seekingalpha after hours gainers  losers seekingalpha sientra sien host analyst day  slideshow seekingalpha sientra eps inline beats on revenue seekingalpha sientra resumed with a market perform at william blair the fly sientra misses by  beats on revenue seekingalpha thestreet quant rating d sell get the sien report here trending starbucks shares are plunging by more than   go out and buy worst performing tech stocks amzn amd mu wdc tesla is a cult stock jim cramer says how do i hate thee amazon let me count the ways us steel shares are being torched thanks to one stock analyst advertising partners  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers sientra inc  sientra announces return of all products to us market search site sientracom investors careers home»news»news details sientra announces return of all products to us market  download this press release pdf  kb santa barbara calif feb   globe newswire  sientra inc nasdaqsien “sientra” or the “company” a medical aesthetics company today announced all of its medical devices including all sientra breast implant products will return to the us market beginning march   sientra is taking this action subsequent to the completion of extensive independent thirdparty testing and analyses of its products in the us  under worstcase testing conditions the products exhibit a high safety margin compared to numerous us and international standards for medical device and materials safety  the conclusive results of our testing indicate no anticipated significant safety concerns with the use of sientra products including our breast implants consistent with their approval status since jeffrey nugent chairman and chief executive officer of sientra said “we are extremely pleased to return our products to the us market where we can once again provide choice to boardcertified plastic surgeons our decision to place the voluntary hold on sientra products was difficult but we felt it was the responsible action to take at the time amid the speculation to ensure that sientra products remain a safe choice for our customers and their patients following the results of independent thirdparty testing we are more confident than ever in the safety of our devices and specifically our breast implant products which are further supported by our year clinical study data to be published in april of   in terms of the confirmation of our manufacturing supply initiatives we are confident that our resupply process will be in place in sufficient time to assure our customers of uninterrupted supply”sientra has also sent a letter to its surgeons informing them of the company’s market reentry plans a copy of that letter can be found in the investor relations section of sientra’s web site or by clicking hereabout sientraheadquartered in santa barbara california sientra is a medical aesthetics company committed to making a difference in patients lives by enhancing their body image growing their selfesteem and restoring their confidence the company was founded to provide greater choice to boardcertified plastic surgeons and patients in need of medical aesthetics products the company has developed a broad portfolio of products with technologically differentiated characteristics supported by independent laboratory testing and strong clinical trial outcomes the company sells its breast implants and breast tissue expanders exclusively to boardcertified and boardadmissible plastic surgeons and tailors its customer service offerings to their specific needs the company also offers a range of other aesthetic and specialty productsforwardlooking statementsthis press release contains forwardlooking statements within the meaning of section a of the securities act of  as amended and section e of the securities exchange act of  as amended relating to among other things the future performance of sientra that are based on managements current assumptions and expectations of future events and involve risks and uncertainties forwardlooking statements include but are not limited to statements regarding the exact date that sientra’s products will return to the us market the interpretation of the results of the thirdparty independent testing of sientra’s products actions that the fda may take in response to such matters and the timing and availability of sources of supply such statements are subject to risks and uncertainties the companys business strategy operations or financial performance and actual results may differ materially from those predicted or implied all statements other than statements of historical fact are forwardlooking statements the words believe may might could will aim estimate continue anticipate intend expect plan or the negative of those terms and similar expressions that convey uncertainty of future events or outcomes are intended to identify estimates projections and other forwardlooking statementsmore information about factors that could cause actual results to differ materially from those contemplated in this press release can be found under the captions risk factors and managements discussion and analysis of financial condition and results of operations in the companys most recent quarterly report on form q at httpinvestorssientracomfinancialinfosecfilingsdefaultaspx or the secs website at wwwsecgov undue reliance should not be placed on the forwardlooking statements in this release which are based on information available to the company on the date hereof and except to the extent required by law sientra assumes no obligation to update such statements contact investor contacts the ruth group nick laudico  brandon vazquez     irsientracom   source sientra inc nasd sien stock quote nasd   volume  previous close  intraday high  intraday low  pricing delayed  minutes price change  change   week high   week low  todays open  jul    pm email alerts email  subscription preferences  press release sec filing event eod stock quote   enter the code shown above  investor contact sientra investor relations  irsientracom script overview  news  events  presentations  stock info  governance  resources   sientra inc all rights reserved privacy statement  terms of use powered by q inc  sientra inc sien  medical equipment  deals and allian inforeportsandmarketscom  uk  us there are no items in your bag sign in register chat with us search home all reports sientra inc sien  medical equipmen sientra inc sien  medical equipment  deals and alliances profile rnm   july   global   pages  globaldata  medical devices report description table of content sample report enquiry before buy check discount summary sientra inc sientra is a medical device company that manufactures and markets plastic surgery implantable devices the companyâs products include body contouring implants pectoral implants gluteal implants oval carving blocks cosmetic and reconstructive surgery devices its reconstructive surgery devices comprise silicone gel breast implants tissue expanders vaginal stents reconstructive products and specialty products it offers services such as simplified account setup monthly credit card style billing system easy orders and returns oneofakind capcon care program and free shipping and returns the company develops aesthetics medicine and plastic surgery implants for both cosmetic and reconstructive sientra is headquartered in santa barbara california the us sientra inc sien  medical equipment  deals and alliances profile provides you comprehensive data and trend analysis of the companys mergers and acquisitions mas partnerships and financings the report provides detailed information on mergers and acquisitions equitydebt offerings private equity venture financing and partnership transactions recorded by the company over a five year period the report offers detailed comparative data on the number of deals and their value categorized into deal types subsector and regions globaldata derived the data presented in this report from proprietary inhouse medical etrack deals database and primary and secondary research scope  financial deals  analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships  deals by year  chart and table displaying information encompassing the number of deals and value reported by the company by year for a five year period  deals by type  chart and table depicting information including the number of deals and value reported by the company by type such as mergers and acquisitions equitydebt offering etc  deals by region  chart and table presenting information on the number of deals and value reported by the company by region which includes north america europe asia pacific the middle east and africa and south and central america  deals by subsector  chart and table showing information on the number of deals and value reported by the company by subsector  major deals  information on the companys major financial deals each such deal has a brief summary deal type deal rationale and deal financials and target companyâs major public companies key financial metrics and ratios  business description  a brief description of the companys operations  key employees  a list of the key executives of the company  important locations and subsidiaries  a list and contact details of key centers of operation and subsidiaries of the company  key competitors  a list of the key competitors of the company  key recent developments  a brief on recent news about the company reasons to buy get detailed information on the companys financial deals that enable you to understand the companys expansiondivestiture and fund requirements  the profile enables you to analyze the companys financial deals by region by year by business segments and by type for a five year period understand the companys business segments expansion  divestiture strategy  the profile presents deals from the companys core business segments perspective to help you understand its corporate strategy access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company  detailed information on major recent deals includes a summary of each deal deal type deal rationale deal financials and target companys key financial metrics and ratios equip yourself with detailed information about the companyâs operations to identify potential customers and suppliers  the profile analyzes the companys business structure locations and subsidiaries key executives and key competitors stay uptodate on the major developments affecting the company  recent developments concerning the company presented in the profile help you track important events gain key insights into the company for academic or business research  key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs note some sections may be missing if data is unavailable for the company table of contents table of contents  list of tables  list of figures  sientra inc medical equipment deals by year  to ytd   sientra inc medical equipment deals by type  to ytd   sientra inc medical equipment deals by region  to ytd   sientra inc medical equipment deals by market  to ytd   sientra inc medical equipment deals summary  to ytd   sientra inc medical equipment deal details  asset purchase  sientra acquires tissue expander portfolio from specialty surgical products  venture financing  sientra raises us million in series c financing  equity offering  sientra raises usd million in public offering of shares  sientra raises usd million in ipo  asset transactions  sientra acquires tissue expander portfolio from specialty surgical products  acquisition  sientra to acquire miramar labs  sientra inc  key competitors  key employees  locations and subsidiaries  head office  other locations  subsidiaries  recent developments  financial announcements  may   sientra reports first quarter  financial results  mar   sientra reports fourth quarter and full year  financial results  nov   sientra reports third quarter  financial results  aug   sientra reports second quarter  financial results and progress on manufacturing solution  may   sientra reports first quarter  financial results  mar   sientra reports fourth quarter and full year  financial results  corporate communications  mar   sientra appoints vidur sahney as vice president operations and supply chain  feb   sientra appoints aesthetic industry leader philippe a schaison to board of directors  feb   sientra announces executive management promotions  product news  feb   sientra announces return of all products to us market  other significant developments  aug   sientra provides update on manufacturing solution  appendix  methodology  about globaldata  contact us  disclaimer  name email job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia faroes fiji finland france gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norway oman pakistan palau panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russian federation rwanda saint lucia samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest please enter code refresh confirm name email job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia faroes fiji finland france gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norway oman pakistan palau panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russian federation rwanda saint lucia samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry please enter code refresh confirm single user license pdf this license allows for use of a publication by one person this person may not print out a single copy of the publication this person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher this person cannot share the publication or any information contained therein with any other person or persons unless a enterprise license is purchased a single user license must be purchased for every person that wishes to use the publication within the same organization customers who infringe these license terms are liable for a global license fee   site license pdf this license allows for use of a publication by all users within one corporate location eg a regional office these users may print out a single copy of the publication these users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher these users cannot share the publication or any information contained therein with any other person or persons outside the corporate location for which the publication is purchased unless a enterprise license is purchased a site user license must be purchased for every corporate location by an organization that wishes to use the publication within the same organization customers who infringe these license terms are liable for a global license fee   global license pdf this license allows for use of a publication by unlimited users within the purchasing organization eg all employees of a single company each of these people may use the publication on any computer and may print out the report but may not share the publication or any information contained therein with any other person or persons outside of the organization these employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher if applicable name email job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia faroes fiji finland france gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norway oman pakistan palau panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russian federation rwanda saint lucia samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your message please enter code refresh submit report you might be interested sientra inc sien  medical equipment  deals and alliances profile sientra inc sien  medical equipment  deals and alliances profile sientra inc sien  medical equipment  deals and alliances profile second sight medical products inc eyes  medical equipment  deals and alliances profile vycor medical inc vyco  medical equipment  deals and alliances profile purchase this report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now sample question discount download pdf refer related reports global database of the top  electromedical and electrotherapeutic equipment producers global database of the top  medical equipment and supply producers global database of the top  surgical and medical instrument producers global database of the top  surgical appliance and supply producers global database of the top  ophthalmic product producers reason to buy trusted by leaders top executives from leading companies purchase research reports from us  shop with confidence we assist you with all the presales enquiries related to any report so that you can buy with confidence customer centric need assistance related to your research requirements we are just a phone call or an email away personalized solutions our experienced research specialists are here to help you locate the right reports for your need secure checkout shop without being worried about safety  security of your transactions × tell a friend about this report your name your email friends name friends email your enquiry send × send to a friend friends details full name email address message to friend your contact details full name email address send reports and markets about us publisher browse by country browse by continent browse by group  region career    contact us office no  empress mill society shree nagar nagpur   maharashtra india ph  uk  us inforeportsandmarketscom support order process blogs faqs privacy policy terms  conditions site map email us view all reports newsletter keep up to date on all the latest reports go copyright   all rights reserved reportsandmarketscom × please enter details to chat your name your email your phone no your message please enter code refresh send sientra inc  governance  management search site sientracom investors careers home»governance»management jeffrey nugent    chairman and ceo view biohide bio jeffrey nugent joined sientra in  as a board member prior to becoming the chairman and ceo in  mr nugent’s experience includes serving as the ceo and worldwide president of neutrogena where he led the acquisition by johnson  johnson neutrogena is regarded as one of the most successful acquisitions in jj history following neutrogena mr nugent became the president and ceo of revlon where he led a turnaround in profitability and a global initiative of new product innovation he was founder president and ceo of precision dermatology a multichannel dermatology and skin care company he established in  the company grew both organically and by ma and was acquired by valeant pharmaceuticals in  he began his career at johnson  johnson where he held a number of senior responsibilities in general management research finance marketing and manufacturing across pharmaceutical medical device and consumer franchises he was appointed vice president of worldwide quality most recently mr nugent had been interim president chief executive officer and a director of biolase inc mr nugent has also served as chairman director president and chief executive officer of a number of aesthetic medicine medical device and consumer focused companies including bioform inc prior to its acquisition by merz aesthetics inc he has also served on the board of the child welfare league of america mr nugent holds a bs in mathematics from st josephs college and earned an mba in finance and marketing from loyola university in chicago he served as an artillery officer in the us army while assigned to military intelligence at the pentagon deborah bettencourt    vice president customer experience and corporate administration view biohide bio deborah bettencourt joined sientra in  ms bettencourt has nearly  years of experience in corporate operations and information technology within the medical device industry she spent much of her professional career at inamed corporation currently allergan medical ms bettencourt served as director of information technology at inamed corporation where she was as an integral part of global information technology implementations business acquisitions system and process integrations and international manufacturing expansions ms bettencourt is a member society for human resource management shrm and holds a ba in psychology from the university of california at santa barbara ms bettencourt also serves on the board of trustees for marymount of santa barbara dan carlisle    vice president of product technology  manufacturing view biohide bio dan carlisle joined sientra in  mr carlisle has nearly  years of innovative product design and development experience as well as technical expertise in the aestheticsurgical market prior to joining sientra mr carlisle was senior director technical marketing at inamed corporation currently allergan medical where he was responsible for designing refining and improving new products for the global aesthetic market additionally he served as director of the internationally recognized inamed academy™ currently allergan academy ® a global education and training platform for surgeons he is named inventor or coinventor on numerous patents in the aesthetic plastic surgery field before inamed mr carlisle held various management positions at silimed corporation based out of brazil and at mcghan medical mr carlisle holds a ba in art from california state university at northridge rosalyn d’incelli    vice president clinical operations view biohide bio rosalyn d’incelli joined sientra in  ms d’incelli has more than  years of clinical research experience coupled with an accomplished record of clinical achievements prior to joining sientra she was the director of clinical studies at mentor corporation where she oversaw many of the company’s studies and managed their clinical resources ms d’incelli was a significant contributor to mentor’s successful siliconegel pma approval and at the time led the company’s large postapproval siliconegel study additionally she served as clinical director for mentor’s phase  botulinum toxin studies and was previously involved in multiple urology studies prior to joining mentor ms d’incelli was employed at inamed corporation currently allergan medical in clinical operations where she was a member of the clinical study team seeking approval for the company’s siliconegel pma she has a demonstrated successful track record in the area of clinical operations with notable clinical studies completions in the areas of breast and facial aesthetics and marketing approvals ms d’incelli holds a ba from the university of california santa barbara and is socra board certified in clinical research charles huiner    chief operating officer and senior vice president of corporate development and strategy view biohide bio charlie huiner joined sientra in  and brings with him a successful track record of more than  years in business development marketing and strategy where in the past  years he served in senior roles in the medical technology and device industries mr huiners medical device and aesthetics experience includes  years at inamed now allergan medical where as senior director of corporate development and strategy his responsibilities spanned business development strategy corporate communications and investor relations at inamed mr huiner served a core role in a number of important partnership and inlicensing transactions including the acquisition of juvéderm® and he was also part of the senior transaction team that executed the  billion sale of inamed to allergan medical immediately prior to joining sientra mr huiner was at intouch health where he served as vice president of business development and marketing at intouch health he led a number of important strategic growth initiatives including conceiving of building and leading the companys btob surgical collaboration business his extensive transactional and strategy transformation expertise is grounded by early career experience in operating and investing roles with security capital group now ge capital and prologis trust he began his career as an ma financial analyst for natwest bancorp mr huiner earned a ba in history from williams college and an mba in finance and marketing from northwestern universitys kellogg school where he concentrated in healthcare management joann kuhne    vice president regulatory affairs  quality assurance view biohide bio joann kuhne joined sientra in  ms kuhne has more than twenty years of global regulatory and clinical experience prior to joining sientra ms kuhne served as senior director regulatory affairs at inamed corporation now allergan medical where she was instrumental in the company’s efforts to obtain pma approval for the company’s silicone gel breast implants before inamed ms kuhne was director of regulatory  clinical affairs at medtronic ps medical leading the company’s global regulatory and clinical efforts for its neurosurgical implants preceding her career at medtronic ps medical and inamed ms kuhne spent several years in the orthopedic implant industry as manager of regulatory affairs for smith and nephew orthopedics and intermedics orthopedics ms kuhne received her bsn from northern michigan university in marquette michigan and an msn from the university of north carolina at chapel hill she is a member of the sigma theta tau international honor society and is board certified in regulatory affairs ms kuhne is an active volunteer at the santa ynez valley therapeutic riding center and is a sponsor for threshold ministries and impact  rich low    vice president of marketing view biohide bio rich low brings more than  years of experience in the aesthetic medicine industry to sientra prior to joining sientra mr low held senior positions at mentor corporation ww llc a division of johnson  johnson where he was responsible for a wide variety of upstream and downstream marketing initiatives in the plastic surgery and nonsurgical markets including new technology development and market creation mr low has introduced a significant number of new products to the aesthetic surgical market including topselling breast implants and breast tissue expanders additionally he led the introduction of new injectable products to europe latin america canada and asia and topical skin care treatments in the us mr low holds an mba from the anderson school of management at ucla an undergraduate degree from uc riverside with a year of undergraduate work at victoria university in wellington new zealand mr low is on the board of directors of the immune deficiency foundation which works to raise funds and awareness for people born with primary immune deficiencies jason o’hearn    vice president of sales view biohide bio jason o’hearn brings more than  years of aesthetic medical device experience to sientra  of those years were spent in seniorexecutive management positions prior to joining sientra mr o’hearn was vice president of sales at mentor corporation ww llc a division of johnson  johnson he was responsible for leading a team of approximately  sales professionals and his efforts resulted in mentor becoming a world leader in breast implant sales mr o’hearn played a vital role in the introduction and acceptance of silicone gel implants into the us market and he has demonstrated a successful track record of moving market share in a highly competitive market mr o’hearn holds ba in business management and a minor in finance from san diego state university mr o’hearn is a volunteer for the mesa beautification committee which raises funds and awareness on how to keep our santa barbara beaches and parks clean vidur sahney    vice president operations and supply chain view biohide bio vidur sahney joined sientra in  having had similar operations leadership roles over the past  years with thoratec now st jude medical loma vista medical now bard peripheral vascular abbott vascular and abbott diabetes care most recently mr sahney served as the senior director of operations at thoratec and was responsible for commercializing and leading the heartmate php program resulting in a successful acquisition by st jude medical prior to this he served as the director of operations for loma vista medical where he helped take a novel class iii fiber composite balloon catheter from conception to commercialization also resulting in an acquisition by bard peripheral vascular mr sahney holds a bs in mechanical engineering from san francisco state university and he learned the fundamentals of lean manufacturing from toyota’s north american contract manufacturer new united motors manufacturing inc or nummi patrick f williams    chief financial officer senior vice president and treasurer view biohide bio patrick f williams joined sientra in  he brings with him nearly  years of financial and operational management experience with public companies most recently serving as senior vice president and chief financial officer at zeltiq aesthetics a medical technology company focused on developing and commercializing products utilizing its proprietary controlledcooling technology platform mr williams was at zeltiq for approximately four years and was responsible for executive management of the finance information technology and investor relations functions development of the worldwide budget and forecast and implementation of necessary infrastructure changes to support topline growth and operating margin expansion prior to zeltiq mr williams served as vice president of strategy and investor relations and vice president of finance and investor relations at nuvasive a medical device company focused on developing minimally surgical products for the spine mr williams also currently serves on the board of directors of miramar labs a medical device company that markets miradry® a system designed for the treatment of hyperhidrosis mr williams received an mba in finance and management from san diego state university and a bachelor of arts in economics from university of california san diego nasd sien stock quote nasd   volume  previous close  intraday high  intraday low  pricing delayed  minutes price change  change   week high   week low  todays open  jul    pm email alerts email  subscription preferences  press release sec filing event eod stock quote   enter the code shown above  investor contact sientra investor relations  irsientracom overview  news  events  presentations  stock info  governance  resources   sientra inc all rights reserved privacy statement  terms of use powered by q inc  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft sientra inc  overview search site sientracom investors careers reshaping theway business is done latest investor news sientra completes acquisition of miramar labs® july   sientra to present at the canaccord genuity growth conference july   view all news latest events upcoming events past events william blair th annual growth stock conference june    am cst join webcast download presentation sientra to acquire miramar labs june    am est join webcast download presentation view all events nasd sien stock quote nasd   volume  previous close  intraday high  intraday low  pricing delayed  minutes price change  change   week high   week low  todays open  jul    pm email alerts email  subscription preferences  press release sec filing event eod stock quote   enter the code shown above  investor contact sientra investor relations  irsientracom overview  news  events  presentations  stock info  governance  resources   sientra inc all rights reserved privacy statement  terms of use powered by q inc  sientra inc nasdaq sien moves toward resolving product issueshomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets close in  minssp  dow  nasdaq todays chartsdont get blindsided by teslas shiny new model sientra inc nasdaq sien moves toward resolving product issuesaccesswirejanuary  reblogsharetweetsharenew york ny  accesswire  january    sientra inc sien shares closed at  up  in fridays session almost  million shares traded friday compared to the daily average of  thousand the sien share price has been moving up in over the past month after a big drop in the fall due to potential product safety concernsfind out what events have been affecting the sien share price follow the link below there is no cost or obligation to review this full reporthttpbitlynyqucopy and paste to browser may be requiredabout sientraheadquartered in santa barbara california sientra is a medical aesthetics company committed to making a difference in patients lives by enhancing their body image growing their selfesteem and restoring their confidence the company was founded to provide greater choice to boardcertified plastic surgeons and patients in need of medical aesthetics products the company has developed a broad portfolio of products with technologically differentiated characteristics supported by independent laboratory testing and strong clinical trial outcomes the company sells its breast implants and breast tissue expanders exclusively to boardcertified and boardadmissible plastic surgeons and tailors its customer service offerings to their specific needs the company also offers a range of other aesthetic and specialty productsabout broad street alertswe make the connection between sophisticated investors and high quality micro and small cap companies an issuer of reports that provide a straightforward assessment of the profiled company they include stocks traded in the nyse nasdaq and otcbb exchangessafe harbor statementthis press release may include forwardlooking statements within the meaning of the private securities litigation reform act of  including statements related to anticipated revenues expenses earnings operating cash flows the outlook for markets and the demand for products forwardlooking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forwardlooking statements such statements are based upon among other things assumptions made by and information currently available to management including managements own knowledge and assessment of the companys industry and competition the company refers interested persons to its most recent annual report on form k and its other sec filings for a description of additional uncertainties and factors which may affect forwardlooking statements the company assumes no duty to update its forwardlooking statementscompliance procedurecontent is researched written and reviewed on a besteffort basis by a rd party analyst however we are only human and may make mistakes if you notice any errors or omissions please notify us this report was prepared for informational purposes only a full disclaimer can be found by viewing the full analyst report we do not hold any positions and have not been compensated in any form for this press release and coinciding reports for more information and services provided beyond this press release please use contact information provided belowcontacteditorbroadstreetalertscomsource broad street alertsreblogsharetweetsharerecently viewedyour list is emptywhat to read nextthe real reason overseas manufacturing is coming to americayahoo financeengineer finds pattern makes millions in stocksmoney morningsponsoredthe two pizza rule is a secret to productive meetings that helped amazon ceo jeff bezos become one of the worlds richest menbusiness insidertax cuts just got more likelyyahoo financegm cadillac chief new ct will replace  sedans evs comingautoblogdiscover it  out of  avg by k customersdiscover cardsponsoredchevron and exxon mobil have a tough path ahead nyse traderyahoo finance videothe government cant help people from making the singlebiggest investing mistakeyahoo financetodays charts dont get blindsided by teslas shiny new model yahoo financezuckerberg wifes ambitious secret finally exposedunewzmesponsoredthe  most profitable markets for home sellerscreditcomnorth korea testfires second icbm lands in sea off japanassociated pressvolkswagen earnings rise in stronger european economyassociated pressthe travel card that is breaking thwise breadsponsoredmy bullish view on stocks hasnt changed one iota nyse traderyahoo finance videothe average person would pay  more for commercialfree cableyahoo financeexclusive majority of americans support transgender military service  pollantilib the poll was taken in san francisco tenderloin districtjoin the conversation  k sientra inc  product pipeline analysis  global market analyst english report store market intelligence home medicine sientra inc  product pipeline analysis sientra inc  product pipeline analysis market medicine global  pages report published by globaldata november description list of figures list of tables toc sientra inc  product pipeline analysissummarysientra inc sientra is a medical device company engaged in the manufacture and marketing of plastic surgery implantable devices it is focused on developing plastic surgery and aesthetics medicine the product pipeline of the company includes cosmetic and reconstructive surgery devices including silicone gel breast implants tissue expanders body contouring implants pectoral implants gluteal implants oval carving blocks vaginal stents reconstructive products and specialty products sientra acquired the assets of silimed inc a leading developer of plastic surgery implants for both cosmetic and reconstructive it operates its business across the globe sientra is headquartered at santa barbara in california the usthis report is a source for data analysis and actionable intelligence on the sientra inc portfolio of pipeline products the report provides detailed analysis on each pipeline product with information on the indication the development stage trial phase product milestones pipeline territory estimated approval date and estimated launch dateeach pipeline product is profiled to cover information on product description function technology indication and application the report is also supplemented with a detailed company profile and information on clinical trials wherever applicablethis report is built using data and information sourced from proprietary databases primary and secondary research and inhouse analysis by globaldata’s team of industry expertsscope detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments detailed coverage on all the pipeline products by equipment type by therapy area by development stage and by trial phase information on product milestones and pipeline territory for each product the estimated approval date and estimated launch date profile of each pipeline product with additional information on product description function technology indications and application data on relevant clinical trials and product patent details wherever applicable information on clinical trial wherever applicable is supplemented with information on trial phase trial status trial objective trial design target patients unique physician identifier primary point secondary point acronym participants inclusion participants exclusion interventions trial results trial start date trial end date study type trial site trial funding age eligibility and gender eligibilityreasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally design and develop your product development marketing and sales strategies exploit ma opportunities by identifying market players with the most innovative pipeline develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials stage and phase of development etc which are the next highvalue products that your competitor would add in its portfolio – identify understand and capitalize list of figures sientra inc pipeline products by equipment type sientra inc pipeline products by development stage  list of tables sientra inc key facts sientra inc key pipeline products by equipment type sientra inc key pipeline products by development stage sientra inc key facts sientra inc major products and services sientra inc number of pipeline products by equipment type sientra inc pipeline products by equipment type sientra inc number of pipeline products by development stage sientra inc pipeline products by development stage silimed enhance  product status silimed enhance  product description silimed nuance  product status silimed nuance  product description silimed smooth round saline implant  product status silimed smooth round saline implant  product description silimed smooth round silicone gel implant  product status silimed smooth round silicone gel implant  product description silimed textured round saline implant  product status silimed textured round saline implant  product description silimed textured round silicone gel implant  product status silimed textured round silicone gel implant  product description sientra inc key employees  table of contents table of contents list of tables list of figures key facts sientra inc  major products and services sientra inc pipeline products by equipment type sientra inc pipeline products by development stage silimed enhance product status product description silimed nuance product status product description silimed smooth round saline implant product status product description silimed smooth round silicone gel implant product status product description silimed textured round saline implant product status product description silimed textured round silicone gel implant product status product description sientra inc  key competitors sientra inc  key employees sientra inc  locations and subsidiaries head office appendix methodology about globaldata contact us disclaimer  please select a license type single user  usd site license  usd global license  usd add to cartcontinue shopping share recently viewed sientra inc  product pipeline analysis related products may point of care testing poct devices companies in china from usd  medicine company report pages china may point of care testing poct devices industry forecasts  china focus from usd  medicine company report pages china april align technology inc algn  product pipeline analysis  update from usd  medicine company report pages united states april nuvasive inc nuva  product pipeline analysis  update from usd  medicine company report pages united states email to a colleague globaldatasientra inc  product pipeline analysissientra inc  product pipeline analysis company reportproduct   copyright   global market analyst all rights reserved